Related Experiment Videos
Nitroglycerine by inhaler as treatment for migraine causing cerebral ischaemia
The Medical Journal of Australia
|November 24, 1999
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Protocol: Using N-of-1 tests to identify responders to melatonin for sleep disturbance in Parkinson's disease.
Contemporary clinical trials communications·2019
Attitudes and practices of general practitioners in the diagnosis and management of attention-deficit/hyperactivity disorder.
Journal of paediatrics and child health·2002
Amine-specificity of the inactivating ornithine decarboxylase modification in Physarum polycephalum.
The Biochemical journal·1982
The Changing Indications for Adult Liver Transplantation in Australia: A Narrative Review.
The Medical journal of Australia·2026
Uneven Ground: Survival Differences Among Victorian Lung Cancer Patients by Location of Residence (2011-2023): A Retrospective Cohort Study.
The Medical journal of Australia·2026
The Timing and Characteristics of Supplemental Indications for Medicines.
The American journal of managed care·2026
Therapeutic effect of Fuzheng Yixin decoction on cardiac insufficiencythe soluble guanylyl cyclase-cyclic guanosine monophosphate-protein kinase G pathway in a doxorubicin-induced dilated cardiomyopathy rat model.
Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan·2026
Shaofu Zhuyu decoction can inhibit the progression of endometriosis fibrosis through the transforming growth factor-β1/ smads signaling pathway mediated by 5' adenosine monophosphate-activated protein kinase.
Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan·2026
Baihe Dihuang decoction activates cannabinoid type 2 receptor to regulate microglial polarization and alleviate anxiety-like behavior in chronic restraint stress mice.
Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan·2026
Real-World Treatment Patterns and Clinical Outcomes with Cyclosporine 0.1% in Semifluorinated Alkane for Dry Eye Disease.
Clinical ophthalmology (Auckland, N.Z.)·2026